{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T12:15:54Z","timestamp":1743077754859,"version":"3.40.3"},"publisher-location":"Cham","reference-count":36,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319190471"},{"type":"electronic","value":"9783319190488"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-3-319-19048-8_30","type":"book-chapter","created":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T14:57:48Z","timestamp":1430319468000},"page":"355-365","source":"Crossref","is-referenced-by-count":1,"title":["The Role of miRNAs in Cisplatin-Resistant HeLa Cells"],"prefix":"10.1007","author":[{"given":"Yubo","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuihong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhipeng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiju","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayou","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dechang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"30_CR1","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/cancers3011351","volume":"3","author":"A.M. Florea","year":"2011","unstructured":"Florea, A.M., Busselberg, D.: Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers\u00a03, 1351\u20131371 (2011)","journal-title":"Cancers"},{"issue":"1","key":"30_CR2","first-page":"3","volume":"7","author":"V. Cepeda","year":"2007","unstructured":"Cepeda, V., Fuertes, M.A., Castilla, J., Alonso, C., Quevedo, C., P\u00e9rez, J.M.: Biochemical mechanisms of cisplatin cytotoxicity. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents)\u00a07(1), 3\u201318 (2007)","journal-title":"Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents)"},{"key":"30_CR3","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1073\/pnas.0307323101","volume":"101","author":"G.A. Calin","year":"2004","unstructured":"Calin, G.A., Sevignani, C., Dumitru, C.D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., Croce, C.M.: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National Academy of Sciences of the United States of America\u00a0101, 2999\u20133004 (2004)","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"30_CR4","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.4161\/cc.5.19.3340","volume":"5","author":"Y. Saito","year":"2006","unstructured":"Saito, Y., Jones, P.M.: Epigenetic Activation of Tumor Suppressor MicroRNAs in Human Cancer Cells. Cell Cycle\u00a05, 2220\u20132222 (2006)","journal-title":"Cell Cycle"},{"key":"30_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.drup.2010.02.001","volume":"13","author":"F.H. Sarkar","year":"2010","unstructured":"Sarkar, F.H., Li, Y., Wang, Z., Kong, D., Ali, S.: Implication of microRNAs in drug resistance for designing novel cancer therapy. Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy\u00a013, 57\u201366 (2010)","journal-title":"Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy"},{"key":"30_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1158\/1535-7163.MCT-07-0573","volume":"7","author":"P.E. Blower","year":"2008","unstructured":"Blower, P.E., Chung, J.H., Verducci, J.S., Lin, S., Park, J.K., Dai, Z., Liu, C.G., Schmittgen, T.D., Reinhold, W.C., Croce, C.M., Weinstein, J.N., Sadee, W.: MicroRNAs modulate the chemosensitivity of tumor cells. Molecular Cancer Therapeutics\u00a07, 1\u20139 (2008)","journal-title":"Molecular Cancer Therapeutics"},{"key":"30_CR7","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1074\/jbc.M111.307405","volume":"287","author":"Z. Zou","year":"2012","unstructured":"Zou, Z., Wu, L., Ding, H., Wang, Y., Zhang, Y., Chen, X., Chen, X., Zhang, C.Y., Zhang, Q., Zen, K.: MicroRNA-30a sensitizes tumor cells to cis-platinum via suppressing beclin 1-mediated autophagy. The Journal of Biological Chemistry\u00a0287, 4148\u20134156 (2012)","journal-title":"The Journal of Biological Chemistry"},{"key":"30_CR8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s004410051072","volume":"292","author":"M. Weller","year":"1998","unstructured":"Weller, M.: Predicting response to cancer chemotherapy: the role of p53. Cell and Tissue Research\u00a0292, 435\u2013445 (1998)","journal-title":"Cell and Tissue Research"},{"key":"30_CR9","first-page":"1373","volume":"90","author":"Y. Minagawa","year":"1999","unstructured":"Minagawa, Y., Kigawa, J., Itamochi, H., Kanamori, Y., Shimada, M., Takahashi, M., Terakawa, N.: Cisplatin-resistant HeLa Cells Are Resistant to Apoptosis via p53-dependent and-independent Pathways. Cancer Science\u00a090, 1373\u20131379 (1999)","journal-title":"Cancer Science"},{"key":"30_CR10","first-page":"1011","volume":"2","author":"G. Abate","year":"1998","unstructured":"Abate, G., Mshana, R.N., Mi\u00f6rner, H.: Evaluation of a colorimetric assay based on 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. The International Journal of Tuberculosis and Lung Disease\u00a02, 1011\u20131016 (1998)","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"key":"30_CR11","doi-asserted-by":"crossref","unstructured":"Cai, Z., Zhang, T., Wan, X.-F.: A Computational Framework for Influenza Antigenic Cartography. PLoS Comput Biol 6(10), e1000949 (2010)","DOI":"10.1371\/journal.pcbi.1000949"},{"key":"30_CR12","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.ygyno.2008.08.017","volume":"111","author":"A. Sorrentino","year":"2008","unstructured":"Sorrentino, A., Liu, C.G., Addario, A., Peschle, C., Scambia, G., Ferlini, C.: Role of microRNAs in drug-resistant ovarian cancer cells. Gynecologic Oncology\u00a0111, 478\u2013486 (2008)","journal-title":"Gynecologic Oncology"},{"key":"30_CR13","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/bioinformatics\/bts043","volume":"28","author":"M. Reczko","year":"2012","unstructured":"Reczko, M., Maragkakis, M., Alexiou, P., Grosse, I., Hatzigeorgiou, A.G.: Functional microRNA targets in protein coding sequences. Bioinformatics\u00a028, 771\u2013776 (2012)","journal-title":"Bioinformatics"},{"key":"30_CR14","doi-asserted-by":"crossref","unstructured":"Paraskevopoulou, M.D., Georgakilas, G., Kostoulas, N., Vlachos, I.S., Vergoulis, T., Reczko, M., Filippidis, C., Dalamagas, T., Hatzigeorgiou, A.G.: DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows. Nucleic Acids Research 41, W169\u2013W173 (2013)","DOI":"10.1093\/nar\/gkt393"},{"key":"30_CR15","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1021\/mp200255d","volume":"8","author":"S. Husted","year":"2011","unstructured":"Husted, S., Sokilde, R., Rask, L., Cirera, S., Busk, P.K., Eriksen, J., Litman, T.: MicroRNA expression profiles associated with development of drug resistance in Ehrlich ascites tumor cells. Molecular Pharmaceutics\u00a08, 2055\u20132062 (2011)","journal-title":"Molecular Pharmaceutics"},{"key":"30_CR16","doi-asserted-by":"crossref","unstructured":"Sui, X., Chen, R., Wang, Z., Huang, Z., Kong, N., Zhang, M., Han, W., Lou, F., Yang, J., Zhang, Q., Wang, X., He, C., Pan, H.: Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death & Disease 4, e838 (2013)","DOI":"10.1038\/cddis.2013.350"},{"key":"30_CR17","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/1471-2407-14-194","volume":"14","author":"M.S. Jami","year":"2014","unstructured":"Jami, M.S., Hou, J., Liu, M., Varney, M.L., Hassan, H., Dong, J., Ding, S.J.: Functional proteomic analysis reveals the involvement of KIAA1199 in breast cancer growth, motility and invasiveness. BMC Cancer\u00a014, 194 (2014)","journal-title":"BMC Cancer"},{"key":"30_CR18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/bjc.2011.268","volume":"105","author":"K. Birkenkamp-Demtroder","year":"2011","unstructured":"Birkenkamp-Demtroder, K., Maghnouj, A., Mansilla, F., Thorsen, K., Andersen, C.L., Oster, B., Hahn, S., Orntoft, T.F.: Repression of KIAA1199 attenuates Wnt-signalling and decreases the proliferation of colon cancer cells. British Journal of Cancer\u00a0105, 552\u2013561 (2011)","journal-title":"British Journal of Cancer"},{"key":"30_CR19","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1093\/jnci\/djt224","volume":"105","author":"N.A. Evensen","year":"2013","unstructured":"Evensen, N.A., Kuscu, C., Nguyen, H.L., Zarrabi, K., Dufour, A., Kadam, P., Hu, Y.J., Pulkoski-Gross, A., Bahou, W.F., Zucker, S., Cao, J.: Unraveling the role of KIAA1199, a novel endoplasmic reticulum protein, in cancer cell migration. Journal of the National Cancer Institute\u00a0105, 1402\u20131416 (2013)","journal-title":"Journal of the National Cancer Institute"},{"key":"30_CR20","unstructured":"Kuscu, C.: Epigenetic Regulations and Promoter Characterization of CERIG (Cancer Endoplasmic Reticulum Gene-KIAA1199) (2012)"},{"key":"30_CR21","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1158\/0008-5472.CAN-08-2334","volume":"69","author":"M. Shiota","year":"2009","unstructured":"Shiota, M., Izumi, H., Tanimoto, A., Takahashi, M., Miyamoto, N., Kashiwagi, E., Kidani, A., Hirano, G., Masubuchi, D., Fukunaka, Y., Yasuniwa, Y., Naito, S., Nishizawa, S., Sasaguri, Y., Kohno, K.: Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth. Cancer Research\u00a069, 3148\u20133156 (2009)","journal-title":"Cancer Research"},{"key":"30_CR22","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/1471-2407-10-354","volume":"10","author":"J. Li","year":"2010","unstructured":"Li, J., Fu, H., Xu, C., Tie, Y., Xing, R., Zhu, J., Qin, Y., Sun, Z., Zheng, X.: miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells. BMC Cancer\u00a010, 354 (2010)","journal-title":"BMC Cancer"},{"key":"30_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1746-1596-9-143","volume":"9","author":"F.L. Ning","year":"2014","unstructured":"Ning, F.L., Wang, F., Li, M.L., Yu, Z.S., Hao, Y.Z., Chen, S.S.: MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4. Diagn. Pathol.\u00a09, 143 (2014)","journal-title":"Diagn. Pathol."},{"key":"30_CR24","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/jcb.24488","volume":"114","author":"Y.Q. Wang","year":"2013","unstructured":"Wang, Y.Q., Guo, R.D., Guo, R.M., Sheng, W., Yin, L.R.: MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas. Journal of Cellular Biochemistry\u00a0114, 1464\u20131473 (2013)","journal-title":"Journal of Cellular Biochemistry"},{"key":"30_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2174\/1568009611313020010","volume":"13","author":"H. Tang","year":"2013","unstructured":"Tang, H., Bian, Y., Tu, C., Wang, Z., Yu, Z., Liu, Q., Xu, G., Wu, M., Li, G.: The miR-183\/96\/182 cluster regulates oxidative apoptosis and sensitizes cells to chemotherapy in gliomas. Current Cancer Drug Targets\u00a013, 221\u2013231 (2013)","journal-title":"Current Cancer Drug Targets"},{"key":"30_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF03256368","volume":"14","author":"W.Q. Wang","year":"2010","unstructured":"Wang, W.Q., Zhang, H., Wang, H.B., Sun, Y.G., Peng, Z.H., Zhou, G., Shi, M.Y., Wang, R.Q., Fang, D.C.: Programmed cell death 4 (PDCD4) enhances the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by inhibiting the PI3K\/Akt signaling pathway. Molecular Diagnosis & Therapy\u00a014, 155\u2013161 (2010)","journal-title":"Molecular Diagnosis & Therapy"},{"key":"30_CR27","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.2174\/138945011796150244","volume":"12","author":"M.S. Wilson","year":"2011","unstructured":"Wilson, M.S., Brosens, J.J., Schwenen, H.D., Lam, E.: FOXO and FOXM1 in cancer: the FOXO-FOXM1 axis shapes the outcome of cancer chemotherapy. Current Drug Targets\u00a012, 1256\u20131266 (2011)","journal-title":"Current Drug Targets"},{"key":"30_CR28","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.3109\/10428194.2012.693178","volume":"53","author":"A. Yang","year":"2012","unstructured":"Yang, A., Ma, J., Wu, M., Qin, W., Zhao, B., Shi, Y., Jin, Y., Xie, Y.: Aberrant microRNA-182 expression is associated with glucocorticoid resistance in lymphoblastic malignancies. Leukemia & Lymphoma\u00a053, 2465\u20132473 (2012)","journal-title":"Leukemia & Lymphoma"},{"key":"30_CR29","doi-asserted-by":"crossref","unstructured":"Gong, C., Bauvy, C., Tonelli, G., Yue, W., Delomenie, C., Nicolas, V., Zhu, Y., Domergue, V., Marin-Esteban, V., Tharinger, H., Delbos, L., Gary-Gouy, H., Morel, A.P., Ghavami, S., Song, E., Codogno, P., Mehrpour, M.: Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like\/progenitor cells. Oncogene 32, 2261\u20132272, 2272e 2261\u20132211 (2013)","DOI":"10.1038\/onc.2012.252"},{"key":"30_CR30","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.4155\/fmc.13.85","volume":"5","author":"F. Aredia","year":"2013","unstructured":"Aredia, F., Scovassi, A.I.: Manipulation of autophagy in cancer cells: an innovative strategy to fight drug resistance. Future Medicinal Chemistry\u00a05, 1009\u20131021 (2013)","journal-title":"Future Medicinal Chemistry"},{"key":"30_CR31","doi-asserted-by":"crossref","unstructured":"Kong, Y.W., Ferland-McCollough, D., Jackson, T.J., Bushell, M.: microRNAs in cancer management. The Lancet Oncology 13, e249\u2013e258 (2012)","DOI":"10.1016\/S1470-2045(12)70073-6"},{"key":"30_CR32","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/cdd.2010.191","volume":"18","author":"R. Kang","year":"2011","unstructured":"Kang, R., Zeh, H.J., Lotze, M.T., Tang, D.: The Beclin 1 network regulates autophagy and apoptosis. Cell Death and Differentiation\u00a018, 571\u2013580 (2011)","journal-title":"Cell Death and Differentiation"},{"key":"30_CR33","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/leu.2012.65","volume":"26","author":"Y. Yu","year":"2012","unstructured":"Yu, Y., Yang, L., Zhao, M., Zhu, S., Kang, R., Vernon, P., Tang, D., Cao, L.: Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells. Leukemia\u00a026, 1752\u20131760 (2012)","journal-title":"Leukemia"},{"key":"30_CR34","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1007\/s12032-009-9344-3","volume":"27","author":"J. Yang","year":"2010","unstructured":"Yang, J., Cao, Y., Sun, J., Zhang, Y.: Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells. Medical Oncology\u00a027, 1114\u20131118 (2010)","journal-title":"Medical Oncology"},{"key":"30_CR35","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/cdd.2009.69","volume":"17","author":"R.I. Aqeilan","year":"2010","unstructured":"Aqeilan, R.I., Calin, G.A., Croce, C.M.: miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death and Differentiation\u00a017, 215\u2013220 (2010)","journal-title":"Cell Death and Differentiation"},{"key":"30_CR36","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/ijc.23501","volume":"123","author":"L. Xia","year":"2008","unstructured":"Xia, L., Zhang, D., Du, R., Pan, Y., Zhao, L., Sun, S., Hong, L., Liu, J., Fan, D.: miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. International Journal of Cancer. Journal International du Cancer\u00a0123, 372\u2013379 (2008)","journal-title":"International Journal of Cancer. Journal International du Cancer"}],"container-title":["Lecture Notes in Computer Science","Bioinformatics Research and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-19048-8_30","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T11:36:18Z","timestamp":1674560178000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-19048-8_30"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9783319190471","9783319190488"],"references-count":36,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-19048-8_30","relation":{},"ISSN":["0302-9743","1611-3349"],"issn-type":[{"type":"print","value":"0302-9743"},{"type":"electronic","value":"1611-3349"}],"subject":[],"published":{"date-parts":[[2015]]}}}